OSI sold for $4B
The pharmaceutical company Astellas Pharma Inc. of Tokyo is buying OSI Pharmaceuticals, Inc. of Melville for $4 billion. Here are the details.

Inside look at NUMC's aging infrastructure President and CEO of Nassau University Medical Center Thomas Stokes explains the problems caused by the aging infrastructure within the hospital. Newsday Associate Editor Joye Brown reports.

Inside look at NUMC's aging infrastructure President and CEO of Nassau University Medical Center Thomas Stokes explains the problems caused by the aging infrastructure within the hospital. Newsday Associate Editor Joye Brown reports.


